Dovish Defeat across Issues and Time: The Pervasive Hawkish Bias in Congress
Foreign Policy Analysis · 09.05.2026 · 22 (3)
DOI: 10.1093/fpa/orag023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Foreign Policy Analysis, online erschienen am 08.07.2026. Verfasst von William Bendix und 1 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben.
Abstract (Originalsprache)
Research shows that hawkish members of Congress enjoy greater legislative success in shaping US foreign policy than their dovish counterparts, regardless of party control of the executive or legislative branches. This congressional bias, combined with the well-documented hawkishness of presidents, has raised concerns about the militarization of American foreign policy. Using mixed methods to capture less visible forms of influence, we examine whether congressional doves secure legislative gains on issues where, in theory, they should hold a relative advantage. In doing so, we assess whether they can overcome the hawkish bias of Congress and the presidency. Our findings, however, reveal a persistent pattern of dovish failure from 1973 to 2022. Across broad categories of bills, specific types of amendments, statistical analyses, and qualitative evidence, we find no consistent legislative success for doves. We conclude that a hawkish bias persists across issues, suggesting stable bipartisan support for a muscular foreign policy.
Zitieren
APA
Bendix, W., & Jeong, G. (2026). Dovish Defeat across Issues and Time: The Pervasive Hawkish Bias in Congress. Foreign Policy Analysis, 22(3). https://doi.org/10.1093/fpa/orag023
Vancouver
Bendix W, Jeong G. Dovish Defeat across Issues and Time: The Pervasive Hawkish Bias in Congress. Foreign Policy Analysis. 2026;22(3). doi:10.1093/fpa/orag023
BibTeX
@article{Bendix2026,
author = {Bendix, William and Jeong, Gyung-Ho},
title = {Dovish Defeat across Issues and Time: The Pervasive Hawkish Bias in Congress},
journal = {Foreign Policy Analysis},
year = {2026},
volume = {22},
number = {3},
doi = {10.1093/fpa/orag023}
}
EUVIMED